Rapport Therapeutics, Inc. Common Stock
RAPP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Operating Activities | – | – | – |
| Net Income | -$78,307 | -$34,786 | -$10,652 |
| Dep. & Amort. | $839 | $112 | $16 |
| Deferred Tax | $0 | $0 | $0 |
| Stock-Based Comp. | $10,235 | $3,525 | $610 |
| Change in WC | -$2,416 | $2,652 | $1,488 |
| Other Non-Cash | $4,821 | $1,316 | $5,296 |
| Operating Cash Flow | -$64,828 | -$27,181 | -$3,242 |
| Investing Activities | – | – | – |
| PP&E Inv. | -$2,405 | -$1,636 | -$284 |
| Net Acquisitions | $0 | $0 | $0 |
| Inv. Purchases | -$380,743 | -$77,224 | $0 |
| Inv. Sales/Matur. | $209,796 | $0 | $0 |
| Other Inv. Act. | $3,211 | $0 | -$5,000 |
| Investing Cash Flow | -$170,141 | -$78,860 | -$5,284 |
| Financing Activities | – | – | – |
| Debt Repay. | $0 | $0 | $7,898 |
| Stock Issued | $157,705 | $54 | $31,787 |
| Stock Repurch. | $0 | -$4 | $0 |
| Dividends Paid | $0 | $0 | $0 |
| Other Fin. Act. | $63,920 | $145,086 | $0 |
| Financing Cash Flow | $221,625 | $145,136 | $39,685 |
| Forex Effect | $0 | $0 | $0 |
| Net Chg. in Cash | -$13,344 | $39,095 | $31,159 |
| Supplemental Information | – | – | – |
| Beg. Cash | $70,254 | $31,159 | $0 |
| End Cash | $56,910 | $70,254 | $31,159 |
| Free Cash Flow | -$67,233 | -$28,817 | -$3,526 |